NeoGenomics (NEO) Competitors $6.29 -0.13 (-2.02%) Closing price 07/25/2025 04:00 PM EasternExtended Trading$6.42 +0.13 (+2.07%) As of 07/25/2025 06:33 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock NEO vs. DLO, TNET, FA, ALIT, YY, CLVT, PAGS, DXC, ACVA, and APLDShould you be buying NeoGenomics stock or one of its competitors? The main competitors of NeoGenomics include DLocal (DLO), TriNet Group (TNET), First Advantage (FA), Alight (ALIT), JOYY (YY), Clarivate (CLVT), PagSeguro Digital (PAGS), DXC Technology (DXC), ACV Auctions (ACVA), and Applied Digital (APLD). These companies are all part of the "business services" industry. NeoGenomics vs. Its Competitors DLocal TriNet Group First Advantage Alight JOYY Clarivate PagSeguro Digital DXC Technology ACV Auctions Applied Digital DLocal (NASDAQ:DLO) and NeoGenomics (NASDAQ:NEO) are both business services companies, but which is the superior business? We will compare the two businesses based on the strength of their analyst recommendations, risk, media sentiment, earnings, institutional ownership, valuation, dividends and profitability. Is DLO or NEO more profitable? DLocal has a net margin of 19.19% compared to NeoGenomics' net margin of -11.54%. DLocal's return on equity of 37.55% beat NeoGenomics' return on equity.Company Net Margins Return on Equity Return on Assets DLocal19.19% 37.55% 15.19% NeoGenomics -11.54%-2.21%-1.22% Which has more volatility and risk, DLO or NEO? DLocal has a beta of 1.11, suggesting that its stock price is 11% more volatile than the S&P 500. Comparatively, NeoGenomics has a beta of 1.63, suggesting that its stock price is 63% more volatile than the S&P 500. Do insiders & institutionals hold more shares of DLO or NEO? 90.1% of DLocal shares are held by institutional investors. Comparatively, 98.5% of NeoGenomics shares are held by institutional investors. 45.4% of DLocal shares are held by company insiders. Comparatively, 2.4% of NeoGenomics shares are held by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company will outperform the market over the long term. Which has higher valuation and earnings, DLO or NEO? DLocal has higher revenue and earnings than NeoGenomics. NeoGenomics is trading at a lower price-to-earnings ratio than DLocal, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioDLocal$745.97M4.14$120.42M$0.4922.10NeoGenomics$660.57M1.23-$78.73M-$0.61-10.31 Does the media refer more to DLO or NEO? In the previous week, NeoGenomics had 6 more articles in the media than DLocal. MarketBeat recorded 9 mentions for NeoGenomics and 3 mentions for DLocal. DLocal's average media sentiment score of 0.98 beat NeoGenomics' score of 0.13 indicating that DLocal is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment DLocal 1 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Positive NeoGenomics 1 Very Positive mention(s) 2 Positive mention(s) 1 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Neutral Do analysts rate DLO or NEO? DLocal currently has a consensus price target of $12.45, suggesting a potential upside of 14.96%. NeoGenomics has a consensus price target of $13.83, suggesting a potential upside of 119.93%. Given NeoGenomics' stronger consensus rating and higher possible upside, analysts plainly believe NeoGenomics is more favorable than DLocal.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score DLocal 0 Sell rating(s) 5 Hold rating(s) 3 Buy rating(s) 0 Strong Buy rating(s) 2.38NeoGenomics 0 Sell rating(s) 6 Hold rating(s) 5 Buy rating(s) 0 Strong Buy rating(s) 2.45 SummaryDLocal beats NeoGenomics on 10 of the 16 factors compared between the two stocks. Get NeoGenomics News Delivered to You Automatically Sign up to receive the latest news and ratings for NEO and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding NEO and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart NEO vs. The Competition Export to ExcelMetricNeoGenomicsMED IndustryMedical SectorNASDAQ ExchangeMarket Cap$826.22M$3.07B$5.70B$9.50BDividend YieldN/A2.37%4.69%4.01%P/E Ratio-10.3121.1828.1020.06Price / Sales1.23283.55428.7189.10Price / Cash14.6342.7636.2258.56Price / Book0.898.378.665.87Net Income-$78.73M-$55.19M$3.25B$258.55M7 Day Performance0.80%5.88%4.22%3.73%1 Month Performance-12.15%17.33%10.51%11.75%1 Year Performance-57.73%4.42%34.40%18.02% NeoGenomics Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)NEONeoGenomics3.7848 of 5 stars$6.29-2.0%$13.83+119.9%-58.3%$826.22M$660.57M-10.312,200Upcoming EarningsAnalyst RevisionDLODLocal2.5298 of 5 stars$10.90+0.2%$12.45+14.2%+41.8%$3.11B$745.97M22.241,095TNETTriNet Group4.2735 of 5 stars$63.65-0.4%$96.67+51.9%-36.6%$3.08B$5.06B19.003,600News CoverageEarnings ReportGap UpFAFirst Advantage1.6052 of 5 stars$17.70+0.4%$66.00+272.9%+8.0%$3.07B$1.05B590.005,500News CoveragePositive NewsALITAlight3.8937 of 5 stars$5.45-0.6%$9.86+81.0%-22.8%$2.93B$2.33B-38.899,500News CoverageDividend AnnouncementYYJOYY1.4145 of 5 stars$53.91-1.3%$35.00-35.1%+53.9%$2.90B$2.24B16.297,450Positive NewsCLVTClarivate1.3443 of 5 stars$4.22-0.4%$4.83+14.7%-34.3%$2.88B$2.56B-4.3512,000Upcoming EarningsPAGSPagSeguro Digital4.4706 of 5 stars$8.00+1.1%$11.36+41.9%-38.2%$2.64B$3.22B6.568,595DXCDXC Technology3.6662 of 5 stars$14.32-0.5%$17.00+18.8%-27.8%$2.59B$12.87B6.78120,000Upcoming EarningsACVAACV Auctions2.3414 of 5 stars$14.96-0.9%$22.05+47.3%-16.9%$2.56B$674.16M-30.542,000News CoverageInsider TradeAPLDApplied Digital3.3487 of 5 stars$11.09-7.0%$12.73+14.8%+141.8%$2.50B$165.57M-8.09121Upcoming EarningsAnalyst Upgrade Related Companies and Tools Related Companies DLocal Alternatives TriNet Group Alternatives First Advantage Alternatives Alight Alternatives JOYY Alternatives Clarivate Alternatives PagSeguro Digital Alternatives DXC Technology Alternatives ACV Auctions Alternatives Applied Digital Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:NEO) was last updated on 7/26/2025 by MarketBeat.com Staff From Our PartnersGoogle did what!?!?A new technology has sparked a modern-day gold rush in Silicon Valley. OpenAI’s Sam Altman invested $375M. Bil...Stansberry Research | SponsoredCritical AI announcement set to ignite AI 2.0 I just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredForget Nvidia, This “Ghost Town” Company Holds the Key to the AI BoomCold War Discovery Could Unlock $100 Trillion in Wealth Jeff recently traveled to an American ghost town to...Brownstone Research | SponsoredBITCOINDid you miss out on the 1000%+ gains of Bitcoin over the past 5 years? If so, you don't want to miss this.....Awesomely, LLC | SponsoredStrait of Hormuz = $100 Oil?Dow Drops 540 Points, Oil Soars Middle East conflict sends markets plunging, oil jumping 8.5%. Investors fl...The Oxford Club | SponsoredThe AI Chip Trade is OUT. This is in…Investing Legend Hints the End May be Near for These 3 Iconic Stocks One company to replace Amazon… another...InvestorPlace | SponsoredElon Musk: “This will transform civilization as we know it.”Robots are no longer science fiction — they’re the next trillion-dollar megatrend. According to Forbes, by ...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding NeoGenomics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share NeoGenomics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free NEO Stock Alerts